NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/11/2025
Back to search
Official data from USPTO
GUUD
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
11/12/2025
Trademark type
Combined
Nice classes
5, 9
Filing date
10/21/2024
Registration date
11/11/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/11/2025
Last transaction
11/12/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
3
Owner type
01
Owner location
Monterrey, Nuevo Leon, MX
Examiner
MAI,TINA HSIN
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of a single line drawing of a smile in white over the stylized wording "GUUD" in white, all over a green background.
Holders and representatives
Holders
GARCIA SADA, FERNANDO
Representatives
Vivian Ortiz-Ponce PEREZ-GUERRERO LLC
Technical classification
Nice Classes
Class 5Class 9
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical products for use in the treatment of metabolic syndromeobesity and overweight; preparations for medical and veterinary use for use in the treatment of metabolic syndromeobesity and overweight; hygienic and sanitary preparations for medical use for treatment of metabolic syndromeobesity and overweight; dietetic food and beverages for medical or veterinary use for use in the treatment of metabolic syndromeobesity and overweight; food supplements for persons or animals; capsules for medicinessold empty for pharmaceuticals; medicines for constipationdragéesfor use in the treatment of metabolic syndromeobesity and overweight; non-steroidal antiinflammatory medicines for use in the treatment of metabolic syndromeobesity and overweight; antifungal medicines; anti-malarial medicines; anti-pyretic medicines; Medicated soap for perspiration; anti-tumor medicines; antitussive medicines; cytostatic medicines for medical use; allergy medicines; diarrhea medicines; non-prescription medicines for use in the treatment of metabolic syndromeobesity and overweight; medicines for adjusting the menstrual cycle; medicine for alleviating allergies; medicines for alleviating pain; acne medicines; medicines for alleviating burns; medicines for the treatment of gastrointestinal diseases; medicines for the prevention of puerperal fever; cough medicines; medicines for medical use for use in the treatment of metabolic syndromeobesity and overweight; medicines for dental use for use in the treatment of metabolic syndromeobesity and overweight; medicines for veterinary use for use in the treatment of metabolic syndromeobesity and overweight serotherapeutic medicines; transdermal patch with medicine featuring preparations for the treatment of metabolic syndromeobesity and overweight; patches containing medicines featuring preparations for the treatment of metabolic syndromeobesity and overweight; preparations for use as medicated additives for food for human consumption for use in the treatment of metabolic syndromeobesity and overweight; sulfonamides as medicines; tonicsmedicinal drinks; medicines for alleviating constipation; diagnostic agents for pharmaceutical use for use in the treatment of metabolic syndromeobesity and overweight; milk ferments for pharmaceutical use; hormone preparations for pharmaceutical use for use in the treatment of metabolic syndromeobesity and overweight; sunburn products for pharmaceutical use for treating sunburn; capsules for pharmaceutical usesold empty for pharmaceuticals; tablets for pharmaceutical usesold empty for pharmaceuticals; cytostatic preparations for pharmaceutical use; amino acid preparations for pharmaceutical use; analgesics for pharmaceutical use; bacteriological preparations for pharmaceutical use; body creams for pharmaceutical use for use in the treatment of metabolic syndromeobesity and overweight; body gels for pharmaceutical use for use in the treatment of metabolic syndromeobesity and overweight
Class 9
Downloadable mobile device applications for telemedicinepurchasing pharmaceutical products and creating medical and lifestyle content; Downloadable software applications for mobile telephones for telemedicinepurchasing pharmaceutical products and creating medical and lifestyle content; downloadable software applications for use with mobile devices for telemedicinepurchasing pharmaceutical products and creating medical and lifestyle content; Downloadable software and software applications for mobile devices for telemedicinepurchasing pharmaceutical products and creating medical and lifestyle content; downloadable mobile applications for use with portable computer devices for telemedicinepurchasing pharmaceutical products and creating medical and lifestyle content; downloadable mobile applications for information management; Downloadable computer application software for mobile phones for telemedicinepurchasing pharmaceutical products and creating medical and lifestyle content; downloadable software being part of a medical device for telemedicinepurchasing pharmaceutical products and creating medical and lifestyle content; Downloadable computer programs relating to the medical field for telemedicinepurchasing pharmaceutical products and creating medical and lifestyle content; scales
Publications
History of USPTO decisions and trademark events.
19 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/11/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/23/2025
PUBO
PUBLISHED FOR OPPOSITION
09/23/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/17/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/24/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/06/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/05/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/05/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/05/2025
GNRT
NON-FINAL ACTION E-MAILED
05/05/2025
CNRT
NON-FINAL ACTION WRITTEN
05/05/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/30/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/30/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/30/2025
DOCK
ASSIGNED TO EXAMINER
04/23/2025
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
04/22/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/22/2025
NWAP
NEW APPLICATION ENTERED
10/21/2024
Continuous trademark protection
Get notified about every new filing that threatens GUUD or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.